Current plasmapheresis practice in the United States
Tóm tắt
The principal differences of the USA plasmapheresis collection system from most other countries are: it is conducted by the pharmaceutical industry rather than government, it uses remunerated donors, and it draws a larger volume of plasma than is permitted elsewhere. The implications of these features are reviewed in terms of the effects on donors and the effects on the plasma supply. Protein metabolism is reviewed, and the effects of plasmapheresis on overall nitrogen balance are presented.
Tài liệu tham khảo
Bistrian B.: Personal communication.
Castillo R., Puig L., Maragall S., Monteagudo J., Labal F., Lozano T., Gelabert A.: Variation in the correlation between the entities of factor VIII during massive plasmapheresis. In: 6th int. Congress on Thrombosis of the Mediterranean League against Thromboembolic Diseases. Monte-Carlo, October 1980; abstract no. 45.
Crispen J. F.: Summary of red blood cell immunization projects conducted by Sera-Tec Biologicals 1967–1978. In:Warner P. J. (Ed.), Plasma Forum, American Blood Resources Association, Berkeley, Calif., 1979, p. 171.
Dawson R. B., Crispen J. F., Ascari W., Sohmer P. R., Miller R. M.: Laboratory profiles on donors participating in long-term plasmapheresis programs. In:Warner P. J. (Ed.): Plasma Forum, American Blood Resources Association, Berkeley, Calif., 1979; p. 141.
Greenwalt T. J.: Plasmapheresis as a source of human plasma. In: Conference on Plasmapheresis, XXth Scientific Meeting of Protein Foundation, Inc., Boston, Mass., April 7, 1966.
Grifols-Lucas J. A.: Use of plasmapheresis in blood donors—Brit. med. J.i, 854, 1952.
Haynes L. L., Tullis J. L.: Complete and partial exchange transfusion, with glycerolized stored red cells suspended in albumin—Vox Sang. (Basel)1, 199, 1961.
Jaffe J. H., Mosher D. F.: Letters to the Editor—New Engl. J. Med.305, 789, 1981.
Kliman A., Carbone P. O., Gaydos L. A., Freireich E. J.: Effects of intensive plasmapheresis on normal blood donors—Blood23, 647, 1964.
McAulev C. et al.: Comparability of one-time-only and long-term plasmapheresis donors— Alpha Therapeutic Co., Los Angeles, Calif., January 1982. (In preparation).
Reasor J.: The rejection and attrition of compensated plasmapheresis donors. In:Warner P. J. (Ed.), Plasma Forum, American Blood Resources Association, Berkeley, Calif., 1979; p. 131.
Rothschild M. A.: Protein synthesis, degradation and limiting factors. In:Warner P. J. (Ed.), Plasma Forum, American Blood Resources Association, Berkeley, Calif., 1979; p. 21.
Smolens J., Stokes J.: The safety and feasibility of bi-weekly plasmapheresis on the same human donors and its effect on antibody levels. In: Xth Conference on the Plasma Proteins and Cellular Elements of the Blood. Protein Foundation, Cambridge, Mass, January 5–7, 1956; p. 63.
Tullis J. L.: Albumin I. Background and use—J. Amer. med. Ass.237, 355, 1977.